Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Pfizer plans to exit 32 percent stake in GSK JV Haleon after demerger

Ruchika Sharma2 Jun 2022 1:14 PM IST

Before the spinoff, the holding company for Haleon will pay dividends to GSK and Pfizer. GSK said it would receive cash proceeds of more than 7...

Medtronic India unveils Pipeline Vantage Embolization Device with shield technology to treat Brain Aneurysms

Ruchika Sharma2 Jun 2022 12:39 PM IST

Cerebral or brain aneurysm is a condition where there is a ballooning or weakening of the inside wall of an artery in brain.

Sanofi India names Preeti Futnani as new General Manager for vaccines

Ruchika Sharma2 Jun 2022 11:57 AM IST

Futnani succeeds Annapurna Das, who is elevated to Head of Vaccines, Asia. Futnani will be based in Mumbai, India.

Pfizer-BioNTech COVID booster authorized in Canada for 16, 17-year-olds

Ruchika Sharma2 Jun 2022 10:00 AM IST

The agency said potential risks of inflammatory heart conditions, myocarditis or pericarditis, have been included in the shot's label.

Regrow Biosciences bags USFDA nod for phase II trial of orphan drug Ossgrow in US

Ruchika Sharma1 Jun 2022 4:05 PM IST

Osteonecrosis, mainly seen in the hip joint, is a progressive bone disease that leads to the death of bone tissue due to interrupted blood supply.

Natco Pharma partner Viatris to launch first generic version of Nexavar tablets in US

Ruchika Sharma1 Jun 2022 2:42 PM IST

Sorafenib is prescribed for treatment of unresectable Hepatocellular Carcinoma (HCC), advanced Renal Cell Carcinoma (RCC) and Differentiated Thyroid...

Supreme Court to hear NEET PG Transparency Plea & Related Matters on Friday

Supreme Court ends Pharmacy Council of India ban on opening new Pharmacy Colleges

Ruchika Sharma1 Jun 2022 1:19 PM IST

New Delhi: In a major move the apex court has overturned the moratorium that was placed by the Pharmacy Council of India on the opening of new...

GSK Nucala application for COPD accepted for review in China

GSK to purchase Affinivax for USD 3.3 Billion

Ruchika Sharma1 Jun 2022 11:30 AM IST

London: GSK plc has announced that the company has entered into a definitive agreement to acquire Affinivax, Inc., a clinical-stage biopharmaceutical...

Sun Pharma expects high single-digit top-line growth in FY23

Ruchika Sharma1 Jun 2022 11:00 AM IST

"R&D investments are expected to be between 7-8 per cent of sales next year," Shanghvi noted.

Moderna gets back Spikevax marketing rights in Japan

Ruchika Sharma1 Jun 2022 10:00 AM IST

In Japan, Spikevax is indicated for the prevention of coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2.

Roche gets USFDA nod for spinal muscular atrophy therapy Evrysdi for babies below 2 months

Ruchika Sharma31 May 2022 4:02 PM IST

Of the babies with 2 or 3 copies of the SMN2 gene (n=6), 100% were able to sit after one year of treatment with Evrysdi, 67% could stand and 50% of...

Sanofi Dupixent under USFDA priority review for adults with prurigo nodularis

Ruchika Sharma31 May 2022 2:41 PM IST

Dupixent is a fully human monoclonal antibody that inhibits the signaling of the interleukin-4 (IL-4) and interleukin-13 (IL-13) pathways and is not...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok